India  

Covaxin gets emergency approval in Nepal

IndiaTimes Sunday, 21 March 2021
India’s first indigenous Covid-19 vaccine Covaxin, developed by Bharat Biotech and Indian Council of Medical Research-National Institute of Virology, Pune, (ICMR-NIV), has now got approval for emergency use in neighbouring Nepal.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related news from verified sources

Nepal gives emergency approval to India's Covaxin


newKerala.com

Nepal gives emergency use approval to Bharat Biotech's Covaxin

Nepal's national drug regulatory authority on Saturday granted emergency use approval to Bharat Biotech's Covaxin, becoming the third country to approve India's...
IndiaTimes